In a relatively more chemotherapy-sensitive tumor like NPC, a formal comparison of chemotherapy and dual checkpoint inhibitors compared to chemotherapy and PD-1 inhibitors in R/M NPC would be required. The gene discussed is PDCD1; the disease is neoplasm.